Pioneering a quantitative,
precision-based approach
to disease diagnosis
and treatment.
Our Purpose
At ModalityDx, we’re constantly innovating to deliver unique and rapid health improvements that transform healthcare. Harnessing advanced data science and molecular innovation to redefine how diseases are detected, understood, and treated.
What We Do
Quantitative diagnosis
Our quantitative rapid point-of-care test technology provides easily accessible, cost-effective tools for disease detection and response to therapy. Our disease areas of focus include:
Maternal health
- Preeclampsia
- Gestational diabetes
Diabetes
- Type 1
- Type 2
Autoimmune
- Rheumatoid arthritis
- COVID antibodies
Patented molecular signatures
To discover disease presence at an individual level, our science identifies biological signatures composed of biomarkers that are accurate and disease-specific.
Drug development strategies
We can help pharmaceutical companies to develop enhanced therapies for targeted diseases.
Therapeutic efficacy
Our technology enables pharmaceutical companies to better assess the efficacy of targeted therapies.
